Cardiovascular Week articles from April 2004

Cardiovascular Week archives from April 2004

Aggressive heart drugs still underused, despite blood chemical status.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Physicians are underutilizing aggressive therapies such as anticlotting drugs and invasive procedures in heart patients, despite the presence of biochemical markers in the blood indicating heart muscle...

Few stroke patients get to the hospital in time for clot-dissolving therapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Only a small proportion of patients who are having a stroke arrive at an emergency department (ED) in time to receive the clot-dissolving therapy, intravenous tissue plasminogen activator (IV tPA),...

Early survival with the total artificial heart shows recent improvement.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Reduced infections and improved survival with the total artificial heart result from better patient management, researchers say. According to a study from Canada, "We report our experience with the...

Cardiac resynchronization reduces all-cause mortality risk.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a large clinical study have confirmed that cardiac resynchronization reduces general mortality risk. "Landmark trials have demonstrated that biventricular pacing (also called cardiac...

Fibrinolytic, cardioprotective enzyme derived from fermented shrimp paste.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A fibrinolytic - and potentially cardioprotective - agent has been isolated from an unlikely source. In a recent study from Canada, a "novel fibrinolytic enzyme was purified from fermented shrimp...

New study demonstrates the benefits of intensive statin therapy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Results from a new study demonstrate the benefit of initiating intensive cholesterol-lowering therapy within 10 days in people hospitalized with an acute coronary syndrome. The TIMI 22 study...

Women with acute coronary syndrome receive less treatment than men, data shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- According to an analysis of more than 35,000 patients, women entering a hospital with acute coronary syndrome (ACS) were less likely than men to receive many medications that have been shown to improve...

Lovenox effective in non-ST-elevation acute coronary syndromes, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a landmark, 10,027-patient study show that Lovenox (enoxaparin sodium injection) is as effective as unfractionated heparin (UFH) in the treatment of high-risk patients with...

Researchers find that coronary aneurysms are independent predictor of mortality.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The results of a study presented at the American College of Cardiology's 53rd Scientific Sessions in New Orleans concludes that coronary aneurysms - regardless of size - are associated with a increased...

Oral formulation of Fasudil improves stable angina in study patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering AG, Germany, (SHR) announced that study patients with stable angina receiving the oral formulation of fasudil showed an improvement in oxygen delivery to the heart. Fasudil, which Schering...

Company reports that interleukin-1 gene variants increase risk for early CHD.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Interleukin Genetics, Inc., (ILGN) reported at the American College of Cardiology meeting that pro-inflammatory variants of the interleukin-1 (IL-1) gene cluster are associated with increased risk for...

LSBC enters research phase for development of atherosclerosis therapeutic.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Large Scale Biology Corp.'s (LSBC) exclusive license agreement with Cincinnati (Ohio) Children's Hospital Medical Center for the development of a drug to treat a leading cause of death in the U.S. has...

Medical device company announces launch of Eagle Eye IVUS imaging catheter.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Volcano Therapeutics, Inc., announced the global launch of its Eagle Eye intravascular ultrasound (IVUS) imaging catheter at the American College of Cardiology 53rd Scientific Session. The Eagle...

PhotoPoint PDT may stabilize atherosclerotic vulnerable plaque.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Miravant Medical Technologies (MRVT), a pharmaceutical development company specializing in PhotoPoint photodynamic therapy (PDT), announced preclinical data that may support the future treatment of...

Study to examine obesity-associated diabetes and heart disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The rise in obesity, now at epidemic levels in the United States, has been matched by a rise in diabetes, a deadly combination that increases heart disease risk by two to five times. Research has...

Cardiology systems provider receives growth strategy excellence award.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Quinton Cardiology Systems has received Frost & Sullivan's Growth Strategy Excellence Award in the global cardiovascular monitoring devices market. According to Frost & Sullivan, the Growth Strategy...

Caelyx demonstrates efficacy, reduced cardiac toxicity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Schering-Plough Europe reported that results of a randomized phase III clinical study demonstrated that Caelyx (pegylated liposomal doxorubicin hydrochloride) provided comparable efficacy in the...

Radiotherapy increases CVD risk but to lesser degree with improvements.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A large study in The Netherlands of breast cancer patients has confirmed that radiotherapy does increase the risk of death from cardiovascular disease, but it has also provided some reassuring findings...

Lymphoseek maker reports annual revenue increase of 32%.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Neoprobe Corp. (NEOP) announced financial results for the fourth quarter of 2003 and for the full year that ended December 31, 2003. Results for the fourth quarter and for the full year of 2003...

Pharmaceutical companies spend over $900M on cholesterol drugs, study shows.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies allocate an average cross-functional budget of $933 million to support cholesterol-lowering drugs, according to a new study launched by Cutting Edge Information. ...

Scripps Research Institute plans Florida research hospital.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The Scripps Research Institute plans to bring a 200-bed research hospital to northern Palm Beach County, Florida, to speed the process of turning research into new treatments for cancer, heart disease,...

Disposable-products maker added to S&P SmallCap 600 Index.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Merit Medical Systems, Inc., (MMSI), a manufacturer and marketer of proprietary disposable products used in radiology and cardiology procedures, was added to the S&P SmallCap 600 Index after the close...

FDA gives market clearance for cardiac stimulation system.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- EP MedSystems, Inc., (EPMD) said the U.S. Food & Drug Administration (FDA) provided market clearance for its new EP-4 Computerized Cardiac Stimulator. The EP-4 offers further advancements in cardiac...

Percutaneous cardiopulmonary support for adult cardiac surgery has risks.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Percutaneous cardiopulmonary bypass support (PCPS) is associated with several risk factors for mortality, such as use for more than 48 hours, researchers say. According to a study from Japan,...

Everolimus may prevent rejection and vasculopathy after heart transplantation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Everolimus may prevent rejection and vasculopathy after heart transplantation. According to published information from New Zealand, "the main cause of illness and death after the first year of heart...

Normative values for pediatric circadian, ultradian CV rhythms determined.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Normative values for pediatric circadian and ultradian cardiovascular rhythms have been determined. "To assess the prevalence and characteristics of physiological circadian (24-hour) and ultradian...

AT1 receptor blocker increases efficacy of ACE inhibitors in murine DHF model.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- AT1 receptor blockade enhances the effects of ACE inhibitor treatment in a murine model of late-stage diastolic heart failure (DHF). DHF "has become a social burden; however, evidences leading to...

Analysis of NHANES data demonstrates high prevalence of CRP.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- New data findings presented from the 1999-2000 National Health and Nutrition Examination Survey (NHANES) show that elevated C-reactive protein (CRP) is a highly prevalent condition in the United States...

Cardiac MRI a better predictor of heart attack, death for women.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The use of non-invasive cardiac magnetic resonance imaging (MRI) appears to be more effective than conventional diagnostic procedures, such as nuclear stress testing and coronary angiography, in the...

Cardioprotective effects of scavenger receptor SR-BI clarified.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The multiple cardioprotective effects of scavenger receptor class B type I (SR-BI) have been characterized. SR-BI "is a multi-ligand receptor that can mediate the binding and bi-directional lipid...

Childhood blood pressure predicts arterial stiffness in young adults.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Childhood blood pressure predicts arterial stiffness in young adults. "Increased arterial stiffness is an independent predictor of cardiovascular disease and mortality in middle-aged and older...

EECP therapy systems receive FDA 510K clearance for revised labeling.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Vasomedical, Inc., (VASO) has been granted a 510(k) market clearance from the U.S. Food and Drug Administration (FDA) for revised labeling on all of the currently available EECP external...

Effects of gap junction signaling during myocardial ischemia-reperfusion reviewed.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The effects of gap junction signaling during myocardial ischemia-reperfusion have been reviewed. "Gap junction-mediated intercellular communication (GJMIC) has been known for a long time to be...

Homocysteine has potent and diverse effects on immune activity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Homocysteine (Hcy) exerts potent and wide-ranging influence on immune activity. Elevated Hcy levels "have been identified as independent risk identifiers for cardiovascular disease, cerebrovascular...

Hyperventilation may underlie CVD in panic disorder patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hyperventilation may underlie the heightened risk of heart disease in panic disorder patients. "Panic disorder is associated with an elevated risk of cardiovascular disease and sudden death,"...

IL-6-174G>C mutation predicts all-cause mortality in octogenarians.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A mutation in the IL-6 gene predicts all-cause mortality in octogenarians. According to recent research from Denmark, "chronic low-grade elevations in circulating levels of interleukin (IL)-6 act as...

Juvenile and adult rabbits respond differently to homocysteine treatment.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The response to exogenous homocysteine administration varies significantly by age in rabbits. "Homocysteine has recently received a lot of attention as an independent risk factor for...

Novel flow cytometry assay aids study of myocardial inflammation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A novel flow cytometry-based assay facilitates the study of myocardial inflammation. "Inflammation has been increasingly recognized as an important pathological component of heart failure,"...

Beta-blocker treatment feasible for many asthma, COPD patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Beta-blocker therapy is feasible for many - but not all - patients with asthma or chronic obstructive pulmonary disease (COPD). "Numerous extensive, randomized clinical trials of beta-blockers have...

Plasmat Futura HELP apheresis system safe and effective.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The Plasmat Futura therapeutic apheresis system is safe and effective for cardiovascular disease patients. Scientists in Germany conducted a study "to examine whether the recently introduced...

Radiofrequency catheter ablation should be used sparingly in small children.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- RFCA should be used sparingly in young children with heart defects, and radiofrequency doses should be limited when it is used. "Little data exists to support the use of procedural modifications...

Surgical therapy for extracranial stenosis of the carotid.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- According to a study from Germany, "The surgical therapy for severe stenosis of the carotid provides a highly effective prophylaxis for carotid-dependent ischemic strokes. After carrying out...

Educational guides to help Texas families address childhood obesity.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Unicare Life & Health Insurance Company announced the donation of 500,000 copies of "Healthy Habits for Healthy Kids" educational guides to the Texas Department of Health (TDH). The guides are...

COPD outcomes study completes patient recruitment.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Boehringer Ingelheim announced completion of patient recruitment - after just 14 months - for the company's large-scale phase IV, 4-year study to evaluate the potential long-term impact of SPIRIVA...

Alliance partners to accelerate development of drug-eluting stent.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- CardioTech International, Inc., (CTE) and Implant Sciences Corporation (IMX.WS) jointly announced that they have joined with CorNova, Inc., to develop and market a new generation drug-eluting stent...

Genaera extends alliance IL-9 alliance.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Genaera Corp. (GENR) and the Ludwig Institute for Cancer Research (LICR) announced a 2-year extension of a collaborative agreement on the joint discovery and development of novel genes and proteins as...

Neurada procumbens has hypertensive effects in mice.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The medicinal plant Neurada procumbens may have dangerous hypertensive effects. N. procumbens "is a desert plant in the Arabian Peninsula," scientists in Saudi Arabia explained. "It has been...

Tai chi has physical, psychological benefits.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A review of previously published studies suggests that among patients with chronic health conditions, Tai Chi appears to have beneficial effects on balance, flexibility, and cardiovascular health. ...

Medicare weighs defibrillator coverage.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Medicare is considering expanding coverage for expensive cardiac defibrillators that are surgically implanted, following a government-funded study that showed the technology significantly reduced deaths...

New device helps reshape damaged hearts.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- After five heart attacks and a stroke, Charles Neal's heart was so worn out that he couldn't walk across a room without feeling exhausted and short of breath. Constant fatigue caused by congestive...

Data supports performance of CYPHER Sirolimus-eluting Coronary Stent.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Long-term follow-up confirms the positive performance of the CYPHER Sirolimus-eluting Coronary Stent in patients with de novo (previously untreated) coronary artery blockages. Four-year findings...

Postoperative infection with MRSA is related to socioeconomic background.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers find patients from deprived areas had a much greater postoperative infection rate than patients from better socioeconomic backgrounds. According to a study from England, "Infectious...

Brachial-ankle pulse wave velocity predicts CAD in men.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- High baPWV predicts CAD in men. "Pulse wave velocity (PWV) is an index of arterial stiffness, and a simple device for measuring brachial-ankle PWV (baPWV) has recently been developed," scientists...

PROCAM Calculator plus CT exam assess future coronary event risk.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- In collaboration with the International Task Force for Prevention of Coronary Heart Disease, Siemens Medical Solutions introduced a refined method for the assessment of a patient's risk for coronary...

Study of twins finds possible mechanism linking depression to heart disease.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Depression is a recognized risk factor for coronary heart disease (CHD), and by studying pairs of twins, researchers from Emory and Yale believe they have found a mechanism that explains this link. ...

Researchers identify gene as essential for vascular smooth muscle development.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Researchers at the University of Texas (UT) Southwestern Medical Center at Dallas have discovered a major mechanism to explain normal and abnormal smooth muscle growth, a finding that could help in the...

Perindopril reduces cardiovascular death and heart attack risk in diabetes study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The long-acting ACE inhibitor perindopril (Coversyl) appears to reduce the risk of cardiovascular death and heart attacks in diabetic patients with stable coronary disease already receiving standard...

First U.S. installation sites of cardiac flat-panel detector announced.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Toshiba America Medical Systems (TAMS) announced the first U.S. installation sites for its works-in-progress cardiac flat-panel detector (FPD) at the University of North Carolina Hospitals - Chapel...

Gd-DTPA safe, effective as contrast agent for MR-angiography.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Gd-DTPA is safe and effective as a contrast agent for magnetic resonance (MR) angiography. "Noninvasiveness, inherent three-dimensionality allowing reformations in any desired plane and safe...

Imaging company enters cardiac diagnostics industry.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Medeikon Corp., a developer of optical and optoelectronic technology for medical imaging, announced that it is developing a new product for the cardiac diagnostics industry and has filed nine additional...

Positive PYY obesity and apomorphine sexual dysfunction trial data reported.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Nastech Pharmaceutical Co., Inc., (NSTK), a drug-delivery technology company, reported positive results from a phase Ib study with PYY 3-36 (PYY) nasal spray for obesity and positive results from a...

Company announces in vivo proof of concept for Anticalins.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- PIERIS Proteolab, AG, a biopharmaceutical and protein engineering company, announced that one of its lead development candidates, Digical, completely neutralized lethal toxicity caused by an overdose of...

Matria Healthcare awarded two new disease management accounts.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Matria Healthcare, Inc., (MATR) has been awarded two new disease management accounts. The company's two most recent awards of business are from one national health plan and one large self-insured...

Medifast forms strategic alliance With XLHealth, Inc.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Medifast, Inc., (MED) has signed a joint venture agreement with XLHealth, Inc., a diabetes-management company. The company's clinically tested Medifast Plus for Diabetics line will be the exclusive...

Weight loss and decreased waist size shown in rimonabant dyslipidemia study.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Results of a phase III clinical trial (RIO-Lipids or Rimonabant In Obesity) comparing rimonabant, the first drug in a new class called selective CB1 blockers (SCB1Bs), to placebo found that overweight...

ADA responds to study citing obesity close to being leading cause of death.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- A new study released by the U.S. Centers for Disease Control and Prevention (CDC) shows that deaths due to poor diet and physical inactivity rose by 33% over the past decade and may soon overtake...

Cardiology capabilities added to hand-carried ultrasound system.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- SonoSite, Inc., (SONO) announced at the American College of Cardiology (ACC) 53rd Annual Scientific Session that it is adding cardiology capabilities to the TITAN system, the company's newest...

Viagra used to treat congestive heart failure, improve quality of life.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- The combination of congestive heart failure and erectile dysfunction can often cause depression, but the drug Viagra can safely work to improve all three disorders, said a new study out of the...

Company reports net losses largely due to ATryn submission.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- GTC Biotherapeutics, Inc., (GTC) (GTCB) reported its financial results for the fourth quarter and year ended December 28, 2003. The total net loss for the quarter was $8.5 million, or $0.27 per...

FDA gives tentative approval for generic version of Tricor tablets.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- IMPAX Laboratories, Inc., (IPXL) announced that the U.S. Food and Drug Administration (FDA) has granted tentative approval to the company's abbreviated new drug application (ANDA) for its generic...

Catheter-based delivery system deploys stem cells to heart attack patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Data from the POZNAN Trial, a human feasibility study evaluating the safety of stem cell delivery via a catheter-based system in heart attack patients, was released at the American College of Cardiology...

Data supports intensive high cholesterol treatment to reduce cardiac events.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Pfizer Inc said that patients taking its cholesterol-lowering medicine Lipitor (atorvastatin calcium) experienced 47% fewer non-fatal heart attacks compared to patients receiving usual care, according...

Plasma lipids augment post-infarction erythrocyte aggregation.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Plasma lipids augment red blood cell aggregation after myocardial infarction. "Increased erythrocyte aggregation (EA) has been observed in patients with ischemic heart disease (IHD), although most...

Many patients can reduce serious risk factors with lifestyle changes alone.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Hypertension, hyperlipidemia and hyperglycemia are serious risk factors for cardiovascular disease, and physicians frequently prescribe a host of medications to treat these problems and reduce these...

Avoidance-based coping linked to heightened mortality risk.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Avoidance-based coping is linked to heightened mortality risk for congestive heart failure (CHF) patients. Researchers in England conducted a study "to evaluate the effects of avoidance coping...

Cardiac resynchronization therapy improves exercise duration in study patients.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- St. Jude Medical, Inc., (STJ) announced that data from its RHYTHM (Resynchronization HemodYnamic Treatment for Heart Failure Management) implantable cardioverter defibrillator (ICD) clinical trial...

Implantable defibrillators reduce death by 23% in trial.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- People with heart failure live longer when they receive an implantable cardioverter-defibrillator (ICD), according to results of the landmark Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). ...

Percutaneous coronary intervention can improve sleep apnea.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Percutaneous coronary intervention can improve sleep apnea. "Central sleep apnea is often recognized in patients with heart failure," cardiologists in Japan explained. "Although the medical...

Study raises questions about chronic diuretics and renal insufficiency.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Data presented from the world's largest heart-failure registry, known as ADHERE (acute decompensated heart failure national registry), raised the question whether chronic diuretics, in widespread use...

Coronary sinus dissection during pacemaker implantation has little effect.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Coronary sinus dissection during pacemaker implantation has surprisingly little clinical effect. According to researchers in the Netherlands, "[d]issection of the coronary sinus during lead...

Common reference values for blood proteins aren't usable in late pregnancy.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Common reference values for blood proteins are not usable in late pregnancy. "During pregnancy, significant changes occur in the hemostatic system and in the plasma levels for several plasma...

Demand for Virginia hospice services grow.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- While her husband was dying of diabetes, congestive heart failure and lung cancer, Toni Johnson sat up many nights in case Irvin, in his delirium, tore away the tubes in his nose that delivered oxygen...

FDA grants tentative approval for Fenofibrate Tablets, 54 mg, 160 mg.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- Teva Pharmaceutical Industries Ltd. (TEVA) announced that the U.S. Food and Drug Administration has granted tentative approval for the company's Abbreviated New Drug Application for Fenofibrate Tablets,...

Sensipar wins FDA approval.
April 5, 2004... 2004 APR 5 - (NewsRx.com & NewsRx.net) -- NPS Pharmaceuticals, Inc., (NPSP) announced that its licensee, Amgen, Inc., (AMGN) of Thousand Oaks, California, has received approval from the U.S. Food and Drug Administration to market Sensipar...